Raymond W. Cohen

Raymond W. Cohen is a seasoned executive and board member with extensive experience in the medical technology sector. Currently serving as an Independent Board Member at Kestra Medical Technologies, Inc. and Chairman of the Board of Directors at SoniVie Ltd, Cohen has a proven track record in leadership roles, including Chief Executive Officer and Board Member at Axonics, Inc., which was acquired by Boston Scientific in November 2024. Previous positions include Chairman of the Board at BioVentrix and Biolife Solutions, Inc., and significant board roles at Spectrum Pharmaceuticals, DYSIS Medical, Lombard Medical, LifeWatch, and Syncroness, Inc. Cohen holds a Bachelor of Science degree in Business Management from Binghamton University and underwent training at the UCLA Director Training & Certification Program in 2016.